1.
A national cohort of HIV-infected patients in Belgium: design and main characteristics.
2.
3.
4.
5.
6.
7.
Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium
Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
8.
9.